Research reveals a process tumors use to induce immune suppressor cells and evade immunotherapy
Cleveland Clinic researchers recently published a study in Cell Reports that shines new light on a next-generation target of immunotherapy—the immune checkpoint protein VISTA.
Feb 9, 2024
0
46